Prelude Capital Management, LLC Champions Oncology, Inc. Transaction History

Prelude Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$5.12 - $8.33 $17,203 - $27,988	-3,360 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$5.4 - $8.99 $259 - $431	-48 Reduced 1.41%	3,360 $19,000
Q2 2019 Aug 14, 2019	SELL	$7.51 - $10.12 $37,504 - $50,539	-4,994 Reduced 59.44%	3,408 $27,000
Q1 2019 May 15, 2019	BUY	$7.89 - $12.23 $19,740 - $30,599	2,502 Added 42.41%	8,402 $82,000
Q4 2018 Feb 14, 2019	BUY	$7.29 - $15.27 $43,011 - $90,093	5,900 New	5,900 $46,000

5.76M

21.6K

Ticker CSBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,522,400
Market Cap $150M
Description
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.